Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma
- 1 June 2006
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 28 (6) , 964-978
- https://doi.org/10.1016/j.clinthera.2006.06.007
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Three-Tiered–Copayment Drug Coverage and Use of Nonsteroidal Anti-inflammatory DrugsArchives of internal medicine (1960), 2004
- Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluationsBMJ, 2004
- The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and SpendingNew England Journal of Medicine, 2003
- Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockersClinical Pharmacology & Therapeutics, 2003
- Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme InhibitorsNew England Journal of Medicine, 2002
- Effect of a Three-Tier Prescription Copay on Pharmaceutical and Other Medical UtilizationMedical Care, 2001
- Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly PersonsJAMA, 2001
- Agreement between Drug Treatment Data and a Discharge Diagnosis of Diabetes Mellitus in the ElderlyAmerican Journal of Epidemiology, 1999
- Bias in the Coding of Hospital Discharge Data and Its Implications for Quality AssessmentMedical Care, 1994
- Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing HomesNew England Journal of Medicine, 1991